XYNGARI™ is the first once-weekly topical product candidate to demonstrate clinical benefit in a Phase 3 clinical trial for moderate-to-severe acne- - Over 30 million acne patients seek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback